Usosayensi Omkhulu
Wenqiang Yu, Ph.D.
●UsoSayensi Omkhulu Wohlelo LukaZwelonke "973";
●USolwazi Oqokwe Ngokukhethekile Wohlelo Lwezazi ze-Chang Jiang;
●PI, Centre for Epigenetics, Institute of Biomedical Sciences Fudan University;
●Umcwaningi Oqokwe Ngokukhethekile kanye Nomphathi Wodokotela waseFudan University;
●Umholi weKomidi Lochwepheshe Be-Methylation Marker weKomidi Lophawu Lwe-Tumor le-Chinese Anti-Cancer Association.
Ngo-1989, waphothula e-Fourth Military Medical University futhi wathola iBachelor's Degree in Medicine;
Ngo-2001, uthole iDegree yakhe yobuDokotela e-Fourth Military Medical University;
Kusukela ngo-2001-2004, uthole i-Postdoctoral eMnyangweni Wezokuthuthukiswa Nezofuzo, i-Uppsala University, eSweden;
Kusukela ngo-2004-2007, uthole i-Postdoctoral e-Hopkins University School of Medicine, e-United States;
Njengamanje, uSolwazi Yu uyi-PI kanye nocwaningo lwe-Institute of Biomedical Sciences yaseFudan University, kanye nePhini Lomqondisi Omkhulu we-Institute of Genomics and Epigenomics yaseFudan University.Izimpumelelo zakhe zocwaningo zishicilelwe kumajenali ezemfundo aphezulu anjengalawa,Imvelo, I-Nature GeneticsfuthiJAMA.
ikhonjiswe kumajenali ezemfundo aphezulu emhlabeni jikelele njenge-Nature, Nature Genetics kanye ne-JAMA, okunomthelela ophezulu kakhulu wamaphoyinti angu-38.1.
CEO
Lin Hua
IBachelor of Economics yase-Shanghai JiaoInyuvesi yaseTong.Usebenze njengoMphathi Omkhulu woMnyango Wenkampani Esohlwini Yezibambiso ze-Guosen, umlingani we-XIANGDU CAPITAL, umlingani ongumsunguli we-CHOBE CAPITAL.Njengomholi weqembu, ukhuthaze ukutshala izinkampani ezimbalwa eziphumelelayo.
I-ObiO(688238): Umkhiqizi we-CGT CDMO enamandla amakhulu;
I-Novoprotein(688137): umphakeli wezinto ezingavuthiwe ogxile kumaprotheni aphinde ahlanganiswe;
I-Leadsynbio: inkampani ehamba phambili ku-synthetic biology;
I-SinoBay: amabhizinisi ahlosiwe wokwelapha isimila
I-Quectel(603236): ibhizinisi lemojula yokuxhumana engenantambo enkulu kunazo zonke emhlabeni
I-XinpelTek: gxila ku-wireless PA RF chip ibhizinisi;
I-DGene: gxila ebhizinisini ledijithali le-3D
Ividiyo++: ibhizinisi le-unicorn endaweni ye-AI
Ngaphezu kweshumi leminyaka emakethe yemali, uNksz Hua useqongelele ulwazi oluhle ekuphathweni kwebhizinisi nokutshalwa kwezimali.
Umqondisi we-R&D
U-Wei Li, Ph.D.
UDokotela uLi usebenze njengoMcwaningi Ohlangene e-Institute of Biological Science Fudan University iminyaka eyishumi.Wengamele amaphrojekthi ocwaningo ama-3 okuhlanganisa neNational Natural Science Foundation yaseChina,ucwaningo oluzimele Iphrojekthi yokwethula amathalentefuthi njll.Uphinde wabamba iqhaza kumaphrojekthi amaningi kazwelonke, okuhlanganisa iNational 973 Project, Key Project yeNational Natural Science Foundation nokunye.Ushicilele amaphepha e-SCI ayi-16 njengombhali wokuqala noma umbhali ohambelana nayeUcwaningo lweGenome, i-eBiomedicine, I-Acid Yenuzi Ucwaningo nokunye.(I-Aggregate Impact Factor 158.97).
Izintshisekelo zocwaningo eziyinhloko:
1. Ukuthuthukiswa kwe-epigenetic algorithms kanye nezifundo eziningi ze-omics ze-tumor pathogenesis.Isixazululo esisodwa esiyisisekelo se-genome-wide DNA methylation sequencing platform (i-algorithm ye-WGPS) yasungulwa ekuqaleni.Bese kutholwe imephu yokuqala ye-DNA methylation ye-genome-wide yonke yamaseli esibindi somuntu.Ngaleso sikhathi, unikeze indlela entsha yokuthulisa i-tumor suppressor gene ekubukeni kwe-epigenetics.
2. Hlola ama-biomarker ajwayelekile okuziphatha okubi ezinhlotsheni eziningi zomdlavuza ngedatha ye-multi-omics.Ngokusekelwe ezindleleni ze-WGPS, sihlole izimpawu ezikhethekile ze-hypermethylation phakathi kwamathumba nokujwayelekile.
3. Ucwaningo nge-pathogenesis ye-gene transcriptional activation by NamiRNA: Isigaba se-nuclear miRNA, esiyiqambe ngokuthi i-NamiRNA (I-Nuclear Activating miRNA).
Unjiniyela we-R&D wezokwelapha
U-Meigui Wang, Ph.D.
Udokotela Wang uthole iPh.D.iziqu azithola eSouth Medical University ngo-2019. Uqhubekile nokuphishekela ukuqeqeshwa okujwayelekile komhlali wakhe eSibhedlela Esihlanganisiwe Sesithathu sase-Sun Yat-sen University(2019-2021).Intshisekelo yakhe yomtholampilo iwukuxilongwa nokwelashwa komdlavuza wekhanda nentamo njengomdlavuza we-laryngeal kanye ne-nasopharyngeal carcinoma.Izintshisekelo zakhe zocwaningo zigxile ekuxilongeni kusenesikhathi kwe-nasopharyngeal carcinoma.
Unjiniyela we-R&D wezokwelapha
Yaping Dong, Ph.D.
UDokotela Dong uthole iPh.D.Iziqu zemithi yokwelapha evela eFujian Medical University ngo-2020, futhi wenza ucwaningo lwangemva kukadokotela eFudan University Shanghai Cancer Centre kusukela ngo-2020 kuya ku-2022. Ukuthuthukiswa Okusha Kwezidakamizwa Okubalulekile”, iNational Natural Science Foundation yaseChina nokunye.Ushicilele amaphepha ambalwa ekhwalithi ephezulu ku-Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica kanye neRadiation Oncology.